Pages that link to "Q43872434"

The following pages link to Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). (Q43872434):

Displaying 45 items.

• Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors (Q24650641) (← links)
• Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder (Q28241583) (← links)
• Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats (Q28297687) (← links)
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders (Q28303826) (← links)
• Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7 (Q28585707) (← links)
• The age of anxiety: role of animal models of anxiolytic action in drug discovery (Q30462832) (← links)
• The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety (Q34340266) (← links)
• Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). (Q34395427) (← links)
• Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice (Q34456979) (← links)
• Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. (Q34564332) (← links)
• In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders (Q34612242) (← links)
• Molecular targets in the treatment of anxiety (Q35001313) (← links)
• Stress-induced hyperthermia and anxiety: pharmacological validation (Q35071492) (← links)
• (-)-2-oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking (Q35478617) (← links)
• The mGlu2/3 Receptor Agonists LY354740 and LY379268 Differentially Regulate Restraint-Stress-Induced Expression of c-Fos in Rat Cerebral Cortex (Q35623415) (← links)
• Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypes. (Q35675641) (← links)
• Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. (Q37103190) (← links)
• Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1 (Q37169626) (← links)
• Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential (Q37773480) (← links)
• Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists (Q37775612) (← links)
• Investigational drugs under development for the treatment of PTSD. (Q38378939) (← links)
• Models of anxiety: stress-induced hyperthermia (SIH) in singly housed mice (Q40388440) (← links)
• Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. (Q40458602) (← links)
• Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. (Q40462255) (← links)
• Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands (Q40498179) (← links)
• Reduced stress-induced hyperthermia in mGluR5 knockout mice (Q40569485) (← links)
• Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325. (Q41786583) (← links)
• Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors (Q42165854) (← links)
• Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors (Q42605827) (← links)
• The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice (Q42607175) (← links)
• Anxiolytic-like activity of zinc in rodent tests (Q42620550) (← links)
• Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor (Q44126409) (← links)
• [3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor (Q44301597) (← links)
• The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats (Q44801606) (← links)
• Effects of Optogenetic inhibition of BLA on Sleep Brief Optogenetic Inhibition of the Basolateral Amygdala in Mice Alters Effects of Stressful Experiences on Rapid Eye Movement Sleep (Q45052755) (← links)
• Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism. (Q45390087) (← links)
• Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair (Q48016277) (← links)
• Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions (Q48106927) (← links)
• Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia (Q48827728) (← links)
• Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice. (Q54667744) (← links)
• Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders (Q57513867) (← links)
• Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1H-imidazol-5-yl)-1H-indole-5-carboxamides, low-basicity 5-HT7 receptor agonists (Q90651120) (← links)
• The Influence of Temperament on Body Temperature Response to Handling in Angus Cattle (Q92853997) (← links)
• Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations (Q94958342) (← links)
• The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus (Q97556098) (← links)